Annual General Shareholder Meeting of

Annual General Shareholder Meeting of May 4, 2016

Paris, France - May 4, 2016 - The Combined General

Shareholder Meeting of Sanofi was held today at the Palais des Congr s in Paris under the chairmanship of Serge Weinberg. All resolutions submitted to the vote were adopted by its shareholders.

The shareholders approved, among other resolutions, the individual Company and consolidated financial statements for the year 2015. At the General Meeting,

shareholders decided the distribution of a cash dividend in the amount of 2.93 per share with payment as of May 12, 2016.

The General Meeting also

approved the appointment of Diane Souza and Thomas S dhof as independent Directors and renewed as Directors Laurent Attal, Claudie Haigner and Carole Piwnica, for a term of four years, i.e., until the General Meeting called to

approve the financial statements for the year 2019.

Following the General Meeting, the new Board of Directors is comprised of 13 members, of whom six are

women. A large majority of the Board s Directors is independent

The voting results will be available on the Company s website

(www.sanofi.com) in the coming days.

The audiocast of the Annual General Shareholder Meeting is available on the Company s website

During the Board of Directors session following the meeting, the Board decided to appoint Diane Souza as a member of the

Compensation Committee.

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi is organized into five

global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).